Early results from Russia’s COVID-19 vaccine showed no negative side effects, a study published in the peer-reviewed medical journal, The Lancet revealed just moments ago.
“Preliminary results from Russian trials find that COVID19 vaccine candidates led to no serious adverse events and elicit an antibody response,” a tweet from the journal’s Twitter account read.
What we know; In Phase 1 and 2 studies of the vaccine, which is named Sputnik V, all 76 study participants developed antibodies to the virus that causes Covid-19, according to Friday’s report in The Lancet.
The levels of neutralizing antibody response were similar to the immune response that people had after naturally recovering from Covid-19, according to the study.
The medical researchers also observed the responses from T cells, another component of the immune system.”[Outcomes from] the trial also suggest the vaccines also produce a T cell response within 28 days,” the researchers wrote.
NEW—Preliminary results from Russian trials find that #COVID19 vaccine candidates led to no serious adverse events and elicit antibody response https://t.co/jGUwQa8oNd
— The Lancet (@TheLancet) September 4, 2020
Thread (1/8) pic.twitter.com/NWBpWDvUK3
